TGFB1 and Myocardial fibrosis: In other words, encapsulation of CAR in NMs enhanced the efficacy of the β‐blocker in reducing the expression of ventricular TGF‐β, contributing to a greater ability to prevent myocardial fibrosis in SH rats.